DEPDC1 and renal cell carcinoma: Additionally, we established sunitinib-resistant RCC cells (786-O-R) and performed in vitro experiment, finding that elevation of the DEPDC1 expression promoted glycolysis and drug resistance in RCC (Fig. 4).